Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT03463993
Eligibility Criteria:
Inclusion Criteria:
* Pregnant woman with signed informed consent\*\*\*
* Understand English and/or Shona
* Estimated gestational age of 38 weeks or older
* Requiring Elective Caesarean Section defined as caesarean section performed before onset of labour
* Live intrauterine fetus
* The study will enrol participants who are Pregnant and who have a signed informed Consent form. Some of the pregnant women may be minors as they are occasionally included in patients planned for elective caesarean section for varying indications. Their inclusion also will make the results of the trial generalizable to elective caesarean section patients attended to at the two study hospitals. Consent will be sought from a legally authorized representative such as the parent or guardian.
Exclusion Criteria:
* Placental Abruption
* Emergency caesarean section
* Current or previous history of significant disease including heart disease, liver, renal disorders
* Known coagulopathy or history of deep venous thrombosis and/or pulmonary embolism, or arterial thrombosis (angina pectoris, myocardial infarction, stroke)
* History of epilepsy or seizures
* Autoimmune disease
* Sickle cell disease
* Severe haemorrhagic disease
* Intrauterine fetal demise
* Eclampsia/HELLP syndrome
* Administration of anticoagulants - clexane or antiplatelet agents in the week prior to delivery
Healthy Volunteers:
True
Sex:
FEMALE
Study:
NCT03463993
Study Brief:
Protocol Section:
NCT03463993